# A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)

> **NCT00751218** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 174 (actual)

## Conditions studied

- Urticaria

## Interventions

- **DRUG:** desloratadine
- **DRUG:** placebo
- **DRUG:** cetirizine

## Key facts

- **NCT ID:** NCT00751218
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-06
- **Primary completion:** 2005-05-24
- **Final completion:** 2005-05-24
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751218, "A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00751218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*